Publications (628) JULIO BELARMINO BOBES GARCIA publications

filter_list

2025

  1. Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study: L’arrêt de l’utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l’étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

    Canadian Journal of Psychiatry, Vol. 70, Núm. 3, pp. 182-193

  2. Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

    Psychological Medicine, Vol. 55

  3. Comparative analysis of gut microbiome-derived short-chain fatty acids in patients with severe mental disorder: Insights from schizophrenia and bipolar disorder

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 138

  4. Methylomic signature of current cannabis use in two first-episode psychosis cohorts

    Molecular Psychiatry, Vol. 30, Núm. 4, pp. 1277-1286

  5. The role of childhood maltreatment and mental health disorders on suicidal behaviour in adolescents

    Child Abuse and Neglect, Vol. 159

  6. Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries

    Psychiatry Research, Vol. 348

  7. Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study

    Acta Psychiatrica Scandinavica, Vol. 151, Núm. 4, pp. 506-520

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

  2. Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?

    Schizophrenia Research: Cognition, Vol. 37

  3. Aprendizaje y memoria verbal: comparación entre pacientes con trastorno por consumo de alcohol y trastorno de depresión mayor

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 1, pp. 21-30

  4. Basic quality indicators for clinical care of patients with major depression, schizophrenia, and bipolar disorder

    Spanish Journal of Psychiatry and Mental Health, Vol. 17, Núm. 2, pp. 103-109

  5. Cannabis use and cognitive biases in people with first-episode psychosis and their siblings

    Psychological Medicine

  6. Clinical predictors and psychosocial risk factors of suicide attempt severity

    Spanish Journal of Psychiatry and Mental Health

  7. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  8. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging

    European Neuropsychopharmacology, Vol. 85, pp. 23-31

  9. Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study

    Journal of Affective Disorders, Vol. 352, pp. 536-551

  10. Platelet and white blood-cell-based ratios: Differential inflammatory markers of severe mental disorders?

    Spanish Journal of Psychiatry and Mental Health

  11. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

  12. PsiOvi Staging Model for Schizophrenia (PsiOvi SMS): A New Internet Tool for Staging Patients with Schizophrenia

    European Psychiatry, Vol. 67, Núm. 1

  13. Psychiatric profiles in suicidal attempters: Relationships with suicide behaviour features

    Spanish Journal of Psychiatry and Mental Health